Metraipolis › archive › dc_c56e34f655cd
Pharmacology of nivegacetor (RG6289), a potent and selective gamma secretase modulator in clinical development for the treatment of Alzheimer's disease — Europe PMC PMID:42292846
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42292846
- DOI
- 10.3389/fphar.2026.1783414
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-01T05:22:43.175Z
- SHA-256 of the archived text
0b6a906ae38387a040ce9f80523b7753f4f8611ac08fa801443656e6f4dec549- Stable URL of this page
https://metraipolis.com/documento/dc_c56e34f655cd
How to cite
Pharmacology of nivegacetor (RG6289), a potent and selective gamma secretase modulator in clinical development for the treatment of Alzheimer's disease — Europe PMC PMID:42292846 — Europe PMC (en), https://europepmc.org/article/MED/42292846 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_c56e34f655cd (Metraipolis archive dc_c56e34f655cd, sha256 0b6a906ae38387a040ce9f80523b7753f4f8611ac08fa801443656e6f4dec549)
BibTeX
@misc{dcc56e34f655cd,
title = {Pharmacology of nivegacetor (RG6289), a potent and selective gamma secretase modulator in clinical development for the treatment of Alzheimer's disease — Europe PMC PMID:42292846},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42292846},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_c56e34f655cd; sha256 0b6a906ae38387a040ce9f80523b7753f4f8611ac08fa801443656e6f4dec549},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42292846. Agents can read the archived copy with the MCP tool read_document.